Copy the short URL in each article and paste it new tab
Thursday, October 6, 2016
Breakingviews: Biotech blues
Robert Cyran and Richard Beales examine why the failure of tests for a single drug caused Alnylam Pharmaceuticals to lose half its $6 bln market capitalization overnight.
from Reuters Video: Breakingviews http://ift.tt/2dVskA3
via IFTTT
No comments:
Post a Comment